American Hotel Income Properties REIT LP (“AHIP”) (TSX: HOT.UN, TSX: HOT.U, TSX: HOT.DB.V), today announced the completion of a non-recourse debt ...

The funding replaces borrowing that supported the construction of the new 52,888-capacity venue, which is set to open early ...

Mortgage giant Rocket has agreed to buy Redfin in an all-stock deal valuing the online real-estate brokerage at $1.75 billion ...

Newmark has arranged a $133 million loan for the refinancing of The Link, an office building located at 200 Elm St. in the southern coastal Connecticut city of Stamford’s downtown area. According to ...

Troubled Australian casino company Star Entertainment received a cash infusion of AUD $53 million ($33.4 million) this week ...

Specialist capital advisory firm Arc & Co. has recently closed a £27.5m facility to refinance the Bristol Airport Hampton by ...

Alvogen Pharma US, Inc. ("Alvogen" or the "Company"), a privately owned US-based pharmaceutical company, announced the successful completion of a comprehensive refinancing of its capital structure.

In addition to the First Lien and Second Lien Term Loans, Alvogen also announced it had successfully amended and extended its existing $240 million ABL revolving credit facility.

Alvogen Pharma US Inc. has arranged a new private loan led by Centerbridge Partners that will ease near-term refinancing pressure as the generic drugs maker grapples with projected revenue declines.

Tourlite Capital Management, an investment management firm, released its fourth quarter 2024 investor letter. A copy of the ...

Around 17 tech companies raise a combined US$6.7 billion from share placements or secondary offerings since February.

Investors including the Abu Dhabi sovereign wealth fund Mubadala are in talks to provide equity financing that would be used ...